(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 6.35% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.77%.
Apyx Medical's revenue in 2025 is $47,288,000.On average, 6 Wall Street analysts forecast APYX's revenue for 2025 to be $1,927,525,980, with the lowest APYX revenue forecast at $1,851,900,414, and the highest APYX revenue forecast at $1,984,367,984. On average, 6 Wall Street analysts forecast APYX's revenue for 2026 to be $2,023,409,069, with the lowest APYX revenue forecast at $1,940,791,634, and the highest APYX revenue forecast at $2,085,428,836.
In 2027, APYX is forecast to generate $2,158,786,768 in revenue, with the lowest revenue forecast at $2,044,498,057 and the highest revenue forecast at $2,254,027,361.